FDA OKs Patch to Treat Depression–うつのパッチ剤

FDA OKs Patch to Treat Depression

Using Emsam in Lower Doses May Avoid Concerns About Drug Interactions By Miranda Hitti

WebMD Medical News Feb. 28, 2006 — The FDA has approved the first skin patch for use in treating major depression.

The once-a-day patch, called Emsam, works by delivering selegiline, a monoamine oxidase inhibitor or MAOI, through the skin and into the bloodstream.

Selegiline isn’t a new drug. It was initially approved in capsule form for use in Parkinson’s disease.




Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s